Aspen Pharmacare Holdings Limited
↗uMhlanga, South Africa
Aspen Pharmacare Holdings Limited is a global specialty and branded multinational pharmaceutical company headquartered in uMhlanga, South Africa. With a 170-year heritage dating back to 1850, the company is the largest pharmaceutical manufacturer in Africa and a major player in emerging and developed markets. Aspen operates 23-24 manufacturing facilities across 15 global sites, serving patients in over 150 countries with a workforce of more than 9,500 employees across 66 offices in 48+ countries. The company specializes in marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands, with manufacturing capabilities spanning steriles, oral solid dose, liquids, semi-solids, biologicals, and active pharmaceutical ingredients.
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$2.5B - $3.5B (estimated based on 10% YoY growth in 2024)
Founded:1850
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:IFC (International Finance Corporation), Proparco, DEG (German Development Finance Institution), DFC (U.S. International Development Finance Corporation), Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI)
STOCK
Exchange:JSE
Ticker:APN
Market Cap:R74.97 billion (approximately $4.1B USD as of late 2024)
PIPELINE
Stage:Commercial (Focus on post-patent branded generics rather than R&D pipeline)
Lead Drug Stage:Commercial portfolio - no single lead candidate; focuses on marketed generics
Modalities:Small molecule, Injectable/Sterile products, Oral solid dose, Liquids, Semi-solids, Biologicals, Active Pharmaceutical Ingredients (APIs), Heparins
Active Trials:0
Trial Phases:-
FDA Approvals:5
CORPORATE STRUCTURE
Subsidiaries:Aspen SA Sterile Operations (Pty) Ltd - South Africa, Alphamed - Hyderabad, India (generic drug development), Aspen Pharma (Pty) Ltd - Australia (formerly Sigma Pharmaceuticals)
Key Partnerships:Novo Nordisk - Human Insulin manufacturing agreement (Gqeberha facility), Serum Institute of India - Vaccine manufacturing and distribution partnership, Strides Pharma Science Limited - Latin America expansion partnership, Debiopharm - Triptorelin Pamoate (oncology) partnership, GlaxoSmithKline (GSK) - Manufacturing rights for antiretrovirals, Merck & Co. - Efavirenz manufacturing license
COMPETITION
Position:Leader - Largest pharmaceutical manufacturer in Africa; significant player in emerging markets
Competitors:Johnson & Johnson, Novartis, Pfizer, Cipla Ltd (India), Sun Pharmaceutical Industries Ltd (India), Teva (Israel), Adcock Ingram Holdings (South Africa), Yifeng Pharmacy Chain +3 more
LEADERSHIP
Key Executives:
Stephen Bradley Saad - Executive Director & Group Chief Executive Officer (Founder)
Kuseni Dlamini - Chairman & Independent Non-Executive Director
Gus Attridge - Executive Director & Deputy Group Chief Executive
Sean Capazorio - Group Finance Officer & Director
Scientific Founders:Stephen Saad (Founder & CEO)
Board Members:Stephen Bradley Saad, Kuseni Dlamini (Chairman), Gus Attridge
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aspen Pharmacare Holdings Limited. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.